Viewing Study NCT06638307



Ignite Creation Date: 2024-10-26 @ 3:42 PM
Last Modification Date: 2024-10-26 @ 3:42 PM
Study NCT ID: NCT06638307
Status: NOT_YET_RECRUITING
Last Update Posted: None
First Post: 2024-10-09

Brief Title: A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
Sponsor: None
Organization: None

Study Overview

Official Title: A Phase 1 First-in-Human Study of MEN2312 a KAT6 Inhibitor as Monotherapy and in Combination in Participants With Advanced Breast Cancer
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This is a first-in-human study of MEN2312 a lysine acetyltransferase 6 KAT6 inhibitor in adult participants with advanced breast cancer
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None